Methods for treating IL-1β related diseases by administering an anti-IL-1β antibody
US8545846B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 4, 2009 |
| Grant date | Oct 1, 2013 |
| Priority date | — |
| Expiry date | Sep 4, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, decreased insulin production, hyperglycemia, hypoinsulinemia, metabolic syndrome, Type 1 diabetes and obesity, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.